A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients-Reference-Cited by-同舟云学术

A phase III study of adjuvant chemotherapy in advanced nasopharyngeal carcinoma patients

Published:2002-04 Issue:5 Volume:52 Page:1238-1244
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Chi Kwan-Hwa,Chang Yue-Cune,Guo Wan-Yao,Leung Mein-Jung,Shiau Cheng-Yin,Chen Sheng-Yu,Wang Ling-Wei,Lai Yuen-Liang,Hsu Mau-Min,Lian Shi-Long,Chang Ching-Hsiung,Liu Tsang-Wu,Chin Yung-Hsin,Yen Sang-Hue,Perng Cheng-Hwang,Chen Kuang Y

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference23 articles.

1. Cancer Registry Annual Report,19982000

2. Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma;Fu;Semin Radiat Oncol,1998

3. The role of chemotherapy in the management of nasopharyngeal carcinoma;Chan;Cancer,1998

4. Is chemotherapy beneficial in the treatment of locoregionally advanced nasopharyngeal carcinoma?;Wong;Cancer,1998

5. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy;Teo;Int J Radiat Oncol Biol Phys,1999

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma;Radiotherapy and Oncology;2024-02

2. Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience;Oncology Research and Treatment;2024

3. Awareness and Knowledge of Nasopharyngeal Cancer in the Western Region in Saudi Arabia: A Cross-sectional Study;Saudi Journal of Otorhinolaryngology Head and Neck Surgery;2024-01

4. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis;The Lancet Oncology;2023-06

5. TRIM29 acts as a potential senescence suppressor with epigenetic activation in nasopharyngeal carcinoma;Cancer Science;2023-05-29